RxDoctor Payments DataLook up a doctor →

Mary Sedarous, MD

Neuromusculoskeletal Medicine & OMM · Neptune, NJNPI 1114187465

Payments from drug & device makers

$45,071in general payments, 2019–2025

Across 1,020 payments — averaging $44.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mallinckrodt Enterprises LLC$21K
  • Mallinckrodt Hospital Products Inc.$9K
  • Novartis$2K
  • AbbVie$1K
  • UCB, Inc.$1K
  • Teva Pharmaceuticals USA, Inc.$1K
  • plus $9K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Mallinckrodt Enterprises LLC6$20,953
Mallinckrodt Hospital Products Inc.5$9,346
Novartis138$1,583
AbbVie(2 entities)95$1,374
UCB, Inc.84$1,352
Teva Pharmaceuticals USA, Inc.105$1,209
AstraZeneca(2 entities)65$1,028
Biogen40$956
Pfizer69$800
Lilly USA, LLC31$475
Argenx US, Inc.30$399
SK Life Science, Inc.19$306
Lundbeck LLC19$292
Catalyst Pharmaceuticals, Inc.5$274
Biohaven Pharmaceutical Holding Company Ltd.25$255
Johnson & Johnson(2 entities)18$251
CSL Behring12$230
Kyowa Kirin, Inc.16$222
Neurelis, Inc.14$204
Bristol Myers Squibb13$196
Eisai Inc.13$186
Biohaven Pharmaceuticals, Inc.15$165
Amneal Pharmaceuticals LLC11$156
Sunovion Pharmaceuticals Inc.8$154
Tanabe Pharma America, Inc.9$144
Avanir Pharmaceuticals, Inc.10$136
Supernus Pharmaceuticals, Inc.11$128
Grifols USA, LLC9$124
Novocure Inc.2$116
Currax Pharmaceuticals LLC8$116
Neurocrine Biosciences, Inc.7$112
Corcept Therapeutics1$111
Sumitomo Pharma America, Inc.6$102
Merz Pharmaceuticals, LLC6$99
Sanofi7$92
Acadia Pharmaceuticals Inc6$90
Servier Pharmaceuticals LLC5$89
Philips North America LLC6$88
EDW Pharma, Inc.1$69
Amgen5$67
Takeda Pharmaceuticals U.S.A., Inc.4$65
Amylyx Pharmaceuticals, Inc.4$64
GE HealthCare3$55
Impel Pharmaceuticals Inc.3$48
Livanova USA, Inc.2$48
Scilex Pharmaceuticals Inc.3$46
Upsher-smith Laboratories LLC2$44
MDD US Operations, LLC3$43
Adamas Pharmaceuticals, Inc.3$42
Nevro Corp.2$42
Avion Pharmaceuticals3$42
Akcea Therapeutics, Inc.3$41
E.r. Squibb & Sons, L.L.C.3$40
Merz North America, Inc.2$34
Jazz Pharmaceuticals Inc.2$33
Tonix Medicines, Inc.2$30
Assertio Therapeutics, Inc.2$28
W. L. Gore & Associates, Inc.2$26
Life Molecular Imaging Ltd2$25
Electromed, Inc.1$18

How this compares

Too few neuromusculoskeletal medicine & omm providers in New Jerseyto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$136,800
Medicare patients
495
Services billed
1,069

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neuromusculoskeletal medicine & omm in Neptune

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →